Traceless directing group for stereospecific nickel-catalyzed alkyl-alkyl cross-coupling reactions

Organic Letters

Volumn 14, Issue 16, 2012, Pages 4293-4296

  Greene, Margaret A ^a   Yonova, Ivelina M ^a   Williams, Florence J ^a   Jarvo, Elizabeth R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZENE DERIVATIVE; DRUG DERIVATIVE; ETHANE; HETEROCYCLIC COMPOUND; NICKEL;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; OXIDATION REDUCTION REACTION; SYNTHESIS;

BENZENE DERIVATIVES; CATALYSIS; ETHANE; HETEROCYCLIC COMPOUNDS; MOLECULAR STRUCTURE; NICKEL; OXIDATION-REDUCTION;

EID: 84865223099     PISSN: 15237060     EISSN: 15237052     Source Type: Journal    
DOI: 10.1021/ol300891k     Document Type: Article

References (36)

1. Taylor, B. L. H.; Jarvo, E. R. Synlett 2011, 19, 2761
2. Jana, R.; Pathak, T. P.; Sigman, M. S. Chem. Rev. 2011, 111, 1417
3. Glorius, F. Angew. Chem., Int. Ed. 2008, 47, 8347
4. Taylor, B. L. H.; Swift, E. C.; Waetzig, J. D.; Jarvo, E. R. J. Am. Chem. Soc. 2011, 133, 389
5. Devasagayaraj, A.; Studemann, T.; Knochel, P. Angew. Chem., Int. Ed. 1995, 34, 2723
6. Didiuk, M. T.; Morken, J. P.; Hoveyda, A. H. Tetrahedron 1996, 54, 1117
7. Interaction between the nickel catalyst and functional groups on the substrate are important during enantioselective nickel-catalyzed cross-coupling of alkyl halides. For a lead reference, see: Zhe, L.; Wilsily, A.; Fu, G. C. J. Am. Chem. Soc. 2011, 133, 8154
8. Srogl, J.; Liu, W.; Marshall, D.; Liebeskind, L. J. Am. Chem. Soc. 1999, 121, 9449
9. Ni, Z. J.; Mei, N. W.; Shi, X.; Tzeng, Y. L.; Wang, M. C.; Luh, T. Y. J. Org. Chem. 1991, 56, 4035
10. For substrate-directed reactions of cuprates, see: Hanessian, S.; Thavonekham, B.; DeHoff, B. J. Org. Chem. 1989, 54, 5831
11. For a representative example of an alternative type of traceless directing group, where a functional group is used first as a directing group and second as a leaving group, see: Wang, C.; Rakshit, S.; Glorius, F. J. Am. Chem. Soc. 2010, 132, 14006
12. For a discussion, see: Kainuma, M.; Kasuga, J.-i.; Hosoda, S.; Wakabayashi, K.-i.; Tanatani, A.; Nagasawa, K.; Miyachi, H.; Makishima, M.; Hashimoto, Y. Bioorg. Med. Chem. Lett. 2006, 16, 3213
13. Anti-lung cancer agent, see: Alami, M.; Messaoudi, S.; Hamze, A.; Provot, O.; Brion, J.-D.; Liu, J.-M.; Bignon, J.; Bakala, J. Patent WO/2009/147217 A1, Dec 10, 2009
14. Anti-viral agent: Cheltsov, A. V.; Aoyagi, M.; Aleshin, A.; Yu, E. C.-W.; Gilliland, T.; Zhai, D.; Bobkov, A. A.; Reed, J. C.; Liddington, R. C.; Abagyan, R. J. Med. Chem. 2010, 53, 3899
15. Anti-prostate cancer agent: Hu, Q. Z.; Yin, L. N.; Jagusch, C.; Hille, U. E.; Hartmann, R. W. J. Med. Chem. 2010, 53, 5049
16. Messaoudi, S.; Hamze, A.; Provot, O.; Tréguier, B.; De Losada, J. R.; Bignon, J.; Liu, J.-M.; Wdzieczak-Bakala, J.; Thoret, S.; Dubois, J.; Brion, J.-D.; Alami, M. Chem. Med. Chem. 2011, 6, 488
17. Shagufta; Srivastava, A. K.; Sharma, R.; Mishra, R.; Balapure, A. K.; Murthy, P. S. R.; Panda, G. Bioorg. Med. Chem. 2006, 14, 1497
18. Pathak, T. P.; Gligorich, K. M.; Welm, B. E.; Sigman, M. S. J. Am. Chem. Soc. 2010, 132, 7870
19. Moree, W. J.; Li, B. F.; Zamani-Kord, S.; Yu, J. H.; Coon, T.; Huang, C.; Marinkovic, D.; Tucci, F. C.; Malany, S.; Bradbury, M. J.; Hernandez, L. M.; Wen, J. Y.; Wang, H.; Hoare, S. R. J.; Petroski, R. E.; Jalali, K.; Yang, C.; Sacaan, A.; Madan, A.; Crowe, P. D.; Beaton, G. Bioorg. Med. Chem. Lett. 2010, 20, 5874
20. Hatanaka, Y.; Hiyama, T. J. Am. Chem. Soc. 1990, 112, 7793
21. Wang, X.; Guram, A.; Caille, S.; Hu, J.; Preston, J. P.; Ronk, M.; Walker, S. Org. Lett. 2011, 13, 1881
22. Imao, D.; Glasspoole, B. W.; Laberge, V. S.; Crudden, C. M. J. Am. Chem. Soc. 2009, 131, 5024
23. Paquin, J.-F.; Defieber, C.; Stephenson, C. R. J.; Carreira, E. M. J. Am. Chem. Soc. 2005, 127, 10850
24. Nave, S.; Sonawane, R. P.; Elford, T. G.; Aggarwal, V. K. J. Am. Chem. Soc. 2010, 132, 17096
25. Lewis, C. A.; Chiu, A.; Kubryk, M.; Balsells, J.; Pollard, D.; Esser, C. K.; Murry, J.; Reamer, R. A.; Hansen, K. B.; Miller, S. J. J. Am. Chem. Soc. 2006, 128, 16454
26. Bolshan, Y.; Chen, C.-y.; Chilenski, J. R.; Gosselin, F.; Mathre, D. J.; O'Shea, P. D.; Roy, A.; Tillyer, R. D. Org. Lett. 2004, 6, 111
27. Podhajsky, S. M.; Iwai, Y.; Cook-Sneathen, A.; Sigman, M. S. Tetrahedron 2011, 67, 4435
28. Denmark, S. E.; Vogler, T. Chem.-Eur. J. 2009, 15, 11737
29. Denmark, S. E.; Burk, M. T.; Hoover, A. J. J. Am. Chem. Soc. 2010, 132, 1232
30. Bolm, C.; Rudolph, J. J. Am. Chem. Soc. 2002, 124, 14850
31. Braga, A. L.; Paixão, M. W.; Westermann, B.; Schneider, P. H.; Wessjohan, L. A. J. Org. Chem. 2008, 73, 2879
32. Moro, A. V.; Tiekink, E. R. T.; Zukerman-Schpector, J.; Lüdtke, D. S.; Correia, C. R. D. Eur. J. Org. Chem. 2010, 3696
33. 3K salts also results in dimerization of starting material. See: Molander, G. A.; Elia, M. D. J. Org. Chem. 2006, 71, 9198
34. Pathak, T. P.; Gligorich, K. M.; Welm, B. E.; Sigman, M. S. J. Am. Chem. Soc. 2010, 132, 7870
35. Moree, W. J.; Li, B.-F.; Jovic, F.; Coon, T.; Yu, J.; Gross, R. S.; Tucci, F.; Marinkovic, D.; Zamani-Kord, S.; Malany, S.; Bradbury, M. J.; Hernandez, L. M.; O'Brien, Z.; Wen, J.; Wang, H.; Hoare, S. R. J.; Petroski, R. E.; Sacaan, A.; Madan, A.; Crowe, P. D.; Beaton, G. J. Med. Chem. 2009, 52, 5307
36. Little, P. J.; Ryan, A. J. Biochem. Pharmacol. 1982, 31, 1795